Why the study?
Do oral contraceptives containing desogestrel and gestodene increase the risk of venous thromboembolism?
Do oral contraceptives containing desogestrel and gestodene increase the risk of venous thromboembolism?
Answers are grounded in this paper and cite their sources.
The principal investigator of a transnational study argues that British regulatory agencies prematurely and misleadingly warned of increased venous thromboembolism risk with third-generation oral contraceptives based on unpublished data.
Data from transnational study of oral contraceptives have been misusedEDITOR,-The unpublished data from the transnational study of oral contraceptives have been misused and misinterpreted in Britain because of inexplicable haste and urgency not thought necessary by other major regulatory agencies.My col- leagues and I do not agree that our findings justify the drastic actions taken in Britian, whereby a "Dear Doctor" letter was sent to doctors, warning that oral contraceptives containing desogestrel and gestodene are associated with an increased risk of thromboembolism (pp 1112, 1117, and 1172).1 Doctors should be vigilant but not stampeded.
No takes yet. Share an insight, caveat, or question.
Walter O. Spitzer (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: